ViewRay Inc. (VRAY)

2.77
NASDAQ : Health Technology
Prev Close 2.73
Day Low/High 2.65 / 2.82
52 Wk Low/High 2.12 / 9.76
Avg Volume 1.88M
Exchange NASDAQ
Shares Outstanding 99.41M
Market Cap 271.38M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT - ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action And Lead Deadline: November 12, 2019

INVESTOR ALERT - ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action And Lead Deadline: November 12, 2019

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ViewRay, Inc.

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against ViewRay, Inc. (VRAY) And November 12 Deadline

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against ViewRay, Inc. (VRAY) And November 12 Deadline

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against ViewRay, Inc.

European Symposium To Advance Adoption Of MRI-Guided Radiation Therapy

European Symposium To Advance Adoption Of MRI-Guided Radiation Therapy

Educational Event to Feature Presentations from MRIdian® Users and ESTRO Past President on the Strategic, Economic, Clinical and Technical Aspects of MRI-Guided Radiation Therapy

It's a Wrap: My Final 40 Triple-Net Stocks

It's a Wrap: My Final 40 Triple-Net Stocks

One thing is certain: Triple-nets are not a common investment hunting ground, but some may be the recipe for the next ETF.

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against ViewRay, Inc. (VRAY) And November 12 Deadline

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against ViewRay, Inc. (VRAY) And November 12 Deadline

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against ViewRay, Inc.

ViewRay Announces Preliminary Third Quarter 2019 Results And Details Of Upcoming Conference Call

ViewRay Announces Preliminary Third Quarter 2019 Results And Details Of Upcoming Conference Call

CLEVELAND, Oct. 15, 2019 /PRNewswire/ -- ViewRay, Inc.

Patient Treatments With ViewRay's MRIdian Linac Begin In New England

Patient Treatments With ViewRay's MRIdian Linac Begin In New England

Joint Cancer Program in Boston First in New England to Offer MRI-Guided Radiation Therapy

VRAY NOTICE: ROSEN, A LEADING LAW FIRM, Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc.

VRAY NOTICE: ROSEN, A LEADING LAW FIRM, Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc.

NEW YORK, Sept. 19, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ViewRay, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ViewRay, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ViewRay, Inc. To Contact The Firm

NEW YORK, Sept. 18, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ViewRay, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against ViewRay, Inc. (VRAY)

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against ViewRay, Inc. (VRAY)

NEW YORK, Sept. 17, 2019 /PRNewswire/ --  Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against ViewRay, Inc.

VRAY CLASS ACTION ALERT: Bernstein Liebhard LLP Announces The Filing Of A Securities Class Action Lawsuit Against ViewRay Inc

VRAY CLASS ACTION ALERT: Bernstein Liebhard LLP Announces The Filing Of A Securities Class Action Lawsuit Against ViewRay Inc

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of ViewRay Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc.

Federman & Sherwood announces that on September 13, 2019, a class action lawsuit was filed in the United States District Court for the Northern District of Ohio against ViewRay, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc. - VRAY

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc. - VRAY

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ViewRay, Inc.

Penn State Health Enters Into Master Purchase Agreement With ViewRay For MRIdian® Systems

Penn State Health Enters Into Master Purchase Agreement With ViewRay For MRIdian® Systems

Immediate order of one system with ability to purchase an additional three systems

ViewRay Announces Collaboration With Stanford Health Care

ViewRay Announces Collaboration With Stanford Health Care

Stanford Health Care to Acquire a ViewRay MRIdian System

Leading Radiation Oncology Meeting To Feature Unique Capabilities And Compelling Patient Outcomes With ViewRay's MRIdian

Leading Radiation Oncology Meeting To Feature Unique Capabilities And Compelling Patient Outcomes With ViewRay's MRIdian

Clinicians from 17 Hospitals Worldwide to Present Clinical Experience with MRIdian MRI-Guided Radiation Therapy at ASTRO

ViewRay (VRAY) Alert: Johnson Fistel Launches Investigation Into ViewRay, Inc.; Investors Encouraged To Contact Firm

ViewRay (VRAY) Alert: Johnson Fistel Launches Investigation Into ViewRay, Inc.; Investors Encouraged To Contact Firm

SAN DIEGO, Sept. 4, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against ViewRay, Inc.

ViewRay To Host Investor Meeting At 2019 ASTRO Annual Meeting In Chicago

ViewRay To Host Investor Meeting At 2019 ASTRO Annual Meeting In Chicago

CLEVELAND, Aug. 27, 2019 /PRNewswire/ -- ViewRay, Inc.

First Week Of November 15th Options Trading For ViewRay (VRAY)

First Week Of November 15th Options Trading For ViewRay (VRAY)

Investors in ViewRay Inc saw new options become available this week, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 86 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ViewRay Announces Results Of The First Prospective Clinical Trial On MR-guided Radiation Treatment For Prostate Cancer Without Implanted Markers

ViewRay Announces Results Of The First Prospective Clinical Trial On MR-guided Radiation Treatment For Prostate Cancer Without Implanted Markers

Study Shows Low Incidence of Early Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Eliminating Potential Complications and Costs Associated with Implanted Markers

ViewRay® To Participate In Upcoming Investor Conferences

ViewRay® To Participate In Upcoming Investor Conferences

CLEVELAND, Aug. 15, 2019 /PRNewswire/ -- ViewRay, Inc.

ViewRay Reports Second Quarter 2019 Results

ViewRay Reports Second Quarter 2019 Results

CLEVELAND, Aug. 8, 2019 /PRNewswire/ -- ViewRay, Inc.

RSI Alert: ViewRay (VRAY) Now Oversold

RSI Alert: ViewRay (VRAY) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ViewRay Announces Conference Call And Webcast Of Second Quarter 2019 Financial Results To Be Held After Market On August 8, 2019

ViewRay Announces Conference Call And Webcast Of Second Quarter 2019 Financial Results To Be Held After Market On August 8, 2019

CLEVELAND, July 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2019 financial results.

TheStreet Quant Rating: D- (Sell)